Available antibody reagents to EBV LMP-1 do not appear to crossreact to LCV LMP-1 homologs [29], therefore, we examined the CD20-positive B-cell lymphomas that showed high LCV levels for expression of EBNA-2 using a monoclonal antibody to EBV EBNA-2 that crossreacts with the LCV EBNA-2 homologs. This evidence concerns the gene PDLIM7 and B-cell non-Hodgkin lymphoma.